Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irosustat vs Megestrol Acetate in Advanced Endometrial Cancer
NCT00910091Phase 2Completed
- Sponsor
- Ipsen
- Start
- Aug 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 12
01
Overview
Phase 2, randomised, open-label trial of irosustat in endometrial cancer (EC) (2 arms), sponsored by Ipsen. Primary endpoint: Percentage of Women With Advanced or Recurrent Endometrial Cancer Who Have Neither Progressed Nor Died at 6 months. Started Aug 2009; status: completed.
02
Drugs
irosustat
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00910091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910091.